13D Filing: Alafi Capital Co LLC and Intra-Cellular Therapies Inc. (ITCI)

Page 4 of 12

Page 4 of 12 – SEC Filing


SCHEDULE 13D
CUSIP No. 46116X 101 Page
4
of 13 Pages
  1 

Name of
reporting person

Moshe Alafi

  2

Check the appropriate box if a member
of a group

(a)  ☐        (b)  ☒ (joint filers)

  3

SEC use only

  4

Source of funds

    OO

  5

Check if disclosure of legal
proceedings is required pursuant to Item 2(d) or 2(e)    ☐

  6

Citizenship or place of
organization

    United States

Number of

shares

beneficially

owned by

each

reporting

person

with

  7 

Sole voting power

    0 shares

  8

Shared voting power

    3,953,270
shares8

  9

Sole dispositive power

    0 shares

10

Shared dispositive power

    3,953,270
shares9

11

Aggregate amount beneficially owned by each reporting person

    3,953,270 shares10

12

Check if the aggregate amount in Row
(11) excludes certain shares    ☐

13

Percent of class represented by amount
in Row (11)

    7.2%11

14

Type of reporting person

    IN

8 Consists of 3,953,270 shares owned by Alafi Capital. The Reporting Person is a managing partner of Alafi Capital and shares voting and investment power with respect to the shares that Alafi Capital holds. The Reporting
Person disclaims beneficial ownership of shares held by Alafi Capital except as to the extent of his pecuniary interest in such shares.
9 See Footnote 8.
10 See Footnote 8.
11 See Footnote 1.

Follow Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

Page 4 of 12